Supplier: GenomeMe
Description:
T-cell Immunoglobulin and Mucin-Domain-Containing Molecule-3 (TIM3) is present on T-helper type 1 lymphocytes and other immune cells including dendritic cells and natural killer cells. TIM3 is overexpressed in CD4+ tumor-infiltrating lymphocytes, including those with non-small cell lung cancer associated with poor prognoses. TIM3 has recently emerged as a potential target for cancer immunotherapy.
Specifications:
Clone |
IHC003 |
Source |
Mouse Monoclonal |
Positive Control |
Tonsil |
Dilution Range |
1:100 - 1:200 |
References
-
Monney L, et al. Nature. 2002; 415:536-41.
-
Sánchez-Fueyo A, et al. Nat Immunol. 2003; 4:1093-101.
-
Anderson AC. Cancer Immun Res. 2014; 2:393–8.
-
Gao X, et al. PLoS One. 2012; 7:e30676.